The Company is a Korea-based Company mainly engaged in the regenerative medicine business. The Company mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The Company also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others. The Company was established on August 02, 2011. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 01, 2018.
Headquarters
607, 606, 605, 474, Dunchon-Daero, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;
Contact Details: Purchase the L & C Bio Co.,Ltd. report to view the information.
Website: http://www.lncbio.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service